This inventor holds 1 USPTO granted patent. Top assignees: Asociacion Civil De Estudios Superiores (Aces), Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet), Fundacion Instituto Leloir (Fil). Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019
Title: Maria C Atorrasagasti: Innovator in Liver Health
Introduction
Maria C Atorrasagasti is a prominent inventor based in Ciudad Autonoma de Buenos Aires, Argentina. She has made significant contributions to the field of liver health through her innovative research and inventions. Her work focuses on identifying new therapeutic targets for the treatment and prevention of acute liver failure.
Latest Patents
Maria C Atorrasagasti holds a patent for her invention titled SPARC (Secreted Protein, Acidic and Rich in Cysteine). This invention relates to the identification of SPARC as a new therapeutic target in patients suffering from fulminant hepatitis. The invention allows for the development of strategies aimed at protecting the liver from damage. It specifically addresses the treatment of acute liver failure by administering agents that inhibit the expression of SPARC and interfere with its biological function. She has 1 patent to her name.
Career Highlights
Throughout her career, Maria has worked with notable organizations such as Inis Biotech LLC and the National Scientific and Technical Research Council (CONICET). Her research has been pivotal in advancing the understanding of liver diseases and potential treatments.
Collaborations
Maria has collaborated with esteemed colleagues, including Guillermo Daniel Mazzolini and Estanislao Peixoto. These partnerships have further enriched her research and contributed to her innovative work in the field.
Conclusion
Maria C Atorrasagasti is a trailblazer in the realm of liver health innovation. Her dedication to research and invention continues to pave the way for new therapeutic approaches in treating acute liver failure.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile